{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.3616.200.110.102.4017",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2020-12-17T01:00:36.000-05:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.4017",
  "version" : "20201217",
  "name" : "COVID19 ICD10PCS Value Set for Administration of Sarilumab",
  "status" : "active",
  "date" : "2020-12-17T01:00:36-05:00",
  "publisher" : "Clinical Architecture",
  "compose" : {
    "include" : [{
      "system" : "http://www.icd10data.com/icd10pcs",
      "version" : "2023",
      "concept" : [{
        "code" : "XW033G5",
        "display" : "Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5"
      },
      {
        "code" : "XW043G5",
        "display" : "Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:55ee5536-770b-43e3-bb87-d0a1c0c18370",
    "timestamp" : "2022-09-27T19:28:52-04:00",
    "total" : 2,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.icd10data.com/icd10pcs",
      "version" : "2023",
      "code" : "XW033G5",
      "display" : "Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5"
    },
    {
      "system" : "http://www.icd10data.com/icd10pcs",
      "version" : "2023",
      "code" : "XW043G5",
      "display" : "Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5"
    }]
  }
}